INSIGHTS ON DRUG DEVELOPMENT

• 3D Biology: The Paradigm Shift In Next-Generation Drug Discovery

  Learn how the transition to 3D biology is aiding scientists in their research and why the industry is embracing organoids for next-gen drug discovery.

• Quantification Of Exenatide Using Xevo TQD

  Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.

• Improve The Performance Of Your Small And Large Molecule Medicines

  Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

• Reduce Costly Scale-Up Problems

  Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.

• Manual Whole-Cell Patch Clamp Assay For Screening NCE's Against Voltage Gated Ion-Channels

  5/13/2025

  Ensure the cardiac safety of your drug candidates by leveraging manual whole-cell patch-clamping to assess their impact on hERG channel interactions and prevent potential QT prolongation risks.

• Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model

  3/28/2025

  Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  6/27/2025

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Preclinical Immuno-Oncology Models For CAR T-Cell Therapy Development

  5/21/2025

  The following preclinical IND-enabling oncology studies conducted by scientists at Aragen over the past 10 years highlight the role of robust preclinical models in advancing the fight against cancer.

• How A Privately Owned CDMO Is Transforming Client Expectations

  5/16/2024

  Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.